Marijuana stocks have gone through a massive roller-coaster ride over the past couple of years. Go back to 2018, and it seemed that even the tiniest companies with ties to cannabis were soaring, even if their business models were unproven. Now, there's just as much pessimism as there was optimism back then, and even well-established leaders in the cannabis industry have felt the pain.

During a recent speech to the United Nations Commission on Narcotic Drugs, a Canadian health official not only touted the government’s commitment to a strict regulatory framework when it comes to cannabis among its accomplishments but also said they wouldn’t recommend other nations take the same approach.

Michelle Boudreau gave the opening remarks for Canada at the 63rd General Debate of the UNCND in Vienna, Austria. In it, she outlined the country’s accomplishments when it comes to domestic and international drug policy.

Unsurprisingly, cannabis figured heavily into the remarks, but less expected were the comments that other countries should not emulate the Canada’s approach to the drug

A poll by Goldbeck Recruiting Inc. indicates that stigma and personal bias may play bigger roles in the potential of the cannabis industry in Canada than previously thought.

Results reflect input from 1,521 members of the Angus Reid Forum, an online public opinion community in which people across Canada answer surveys on various topics in exchange for points that can be redeemed for prizes or rewards.

Goldbeck gleaned data from the polls in creating its 2020 Cannabis Labour Market report, which explores why job-seekers are willing (or not willing) to work in the cannabis industry.

Before cannabis edibles arrived on the market in late 2019 and early 2020, there were heated discussions about Health Canada’s limit on cannabinoid content: 10 mg would the maximum amount of THC and CBD per package, whether it was two milligrams of five candies, or one chocolate bar containing 10 mg.

Some cannabis aficionados decried what they perceived as a far-too-low level of THC, especially for those with a higher tolerance or who had already been sampling products labelled with amounts as high as 200 mg on the illicit market. But Health Canada stayed firm, citing concerns about keeping curious children safe from harrowing accidental doses.

What happened

Shares of Aurora Cannabis (NYSE:ACB) were up 3.4% as of 11:26 a.m. EDT on Tuesday after rising as much as 12.6% earlier in the day. The Canadian cannabis producer didn't have any news of its own. Instead, today's move is part of an overall rebound for the stock market after Monday's massive sell-off.

Cannabis infused beverages is an area of major interest for companies, investors and consumers, and is a vertical that we have been focused on.

Although this has been area of interest for companies, there are a limited number of cannabis infused beverages that are on the market and this is a trend that our readers should be aware of. The lack of products on the market implies that there is a significant opportunity for companies with an MVP (minimum viable product) ready to go to market.

Strong cash positions and the ability to negotiate with suppliers will be key for cannabis companies looking to withstand any operational disruption caused by COVID-19, according to one leading cannabis analyst.

Eight Capital’s Graeme Kreindler wrote in a report Monday that the rise of coronavirus cases globally is likely to see the cannabis sector in North America face the supply chain pressures that other industries are already facing – mainly sourcing items from China and finding protective gear.

Pot stocks were hammered in 2019. Nearly every company lost at least 50% of its value. Cannabis demand, on the other hand, continues to climb. This disconnect provides patient investors a clear path to profit.

As with any early-stage market, investors scrambled at the chance to inject pent-up capital into cannabis companies. In 2018, many pot stocks rose by more than 1,000%. By 2019, the hype bubble had popped, sending short-term investors to the sidelines.

Pot stocks were overvalued in 2018, but there’s an argument that the pendulum has swung too far the other way. It doesn’t take a mathematician to realize that many cannabis producers are trading at bargain valuations.

s the illicit market continues to dominate Canada’s pot industry, one company is on a mission to teach provinces how craft cannabis can save the struggling legal regime.

B.C.-based processor Shelter announced last week the launch of its Craft Collective Division, an in-house service designed to assist and promote small farmers into the legal market.

Last week one of the subjects we touched on was the perception of oversupply in the cannabis market and the reality that it’s a bit more complex than companies overgrowing. One of the most important things to keep track of with regards to the Canadian LP and the Marijuana Stock market is not just the supply of cannabis, but the ability to bring that dried flower and finished product to market. To understand why things are the way they are currently we must first understand what the initial goals for Canadian legalization were and the issues that brought us to this point.